PHILADELPHIA CHROMOSOME-POSITIVE ACUTE MYELOID LEUKEMIA
Clinical trials for PHILADELPHIA CHROMOSOME-POSITIVE ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME-POSITIVE ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME-POSITIVE ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug attack targets Hard-to-Treat leukemias
Disease control Recruiting nowThis early-phase study tests a combination of three drugs (decitabine, lisaftoclax, and olverembatinib) in 30 adults with advanced chronic myeloid leukemia or a related acute leukemia. The goal is to find safe doses and see if the combo can control the disease in people who have …
Matched conditions: PHILADELPHIA CHROMOSOME-POSITIVE ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could removing metals boost chemo in leukemia?
Disease control Recruiting nowThis phase 2 trial tests whether adding metal detoxification drugs (DMSA and Ca-EDTA) to standard therapy can improve outcomes for adults with intermediate- to high-risk acute myeloid leukemia (AML). Researchers believe lowering metal levels in blood and bone marrow may help cont…
Matched conditions: PHILADELPHIA CHROMOSOME-POSITIVE ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart shield: new trial aims to prevent chemo side effects in blood cancer patients
Symptom relief Recruiting nowThis study tests whether a drug called dexrazoxane can protect the heart from damage caused by chemotherapy in people with certain blood cancers, such as acute myeloid leukemia and high-risk myelodysplastic syndrome. About 100 participants will receive dexrazoxane alongside stand…
Matched conditions: PHILADELPHIA CHROMOSOME-POSITIVE ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC